CHELATION OF BAND KERATOPATHY IN LONG-TERM MONITORING

Česká verzia

Authors: P. Kristian; D. Cholevík
Authors place of work: Gemini oční klinika Ostrava
Published in the journal: Čes. a slov. Oftal., 78, 2022, No. 5, p. 250-256
Category: Původní práce
doi: https://doi.org/10.31348/2022/26

Summary

Aim: To report the clinical results of chelation of band keratopathy in long-term follow-up.

Material and methods: The long-term results of 5 patients (5 eyes) with symptomatic band keratopathy with a follow-up period of at least 6 months, in whom 2% EDTA was chelated on the affected eye in the study period from April 2018 to March 2021, were retrospectively evaluated. The follow-up period was 9-37 months.

Results: In all patients, there was a significant improvement in the local findings and an increase in the transparency of the cornea. The effect of therapy was verified on a color photograph of the anterior segment and on AS-OCT by the disappearance of subepithelial hyperreflective foci and accompanying optical shadows. Postoperatively, this enabled a more detailed visualization of the deeper layers of the cornea and other structures of the anterior segment. In a patient with the potential to improve vision, it was also possible to significantly improve visual functions. In the other three patients with pain in the affected eye, the pain subsided, and they also benefited cosmetically from the operation.

Conclusion: Based on our experience and previously published reports, EDTA corneal chelation is able to causally resolve the pathology and improve vision in eyes with visual potential. At the same time, it reduces discomfort and has an analgesic effect in long-term irritated eyes. The operation is also suitable for amaurotic, cosmetically unsightly bulbs, as a successful intervention preserving the eye and improving the appearance of such eyes leads to satisfaction and a subjective increase in the quality of life of the patients.

Keywords:

OCT – anterior segment optical coherence tomography – band keratopathy – chelation – ethylenediaminetetraacetic acid – EDTA

Zdroje

1. Kanski JJ, Bowling B. Clinical Ophthalmology: a systematic approach. 7th ed. Edinburgh: Elsevier Saunders; 2003. 909.

2. Lee ME, Ouano DP, Shapiro B, Fong A, Coroneo MT. “Off-the-Shelf” K2-EDTA for Calcific Band Keratopathy. Cornea. 2018 Jul;37(7):916- 918.

3. Wee-Min Teh, Mohtar Ibrahim. Acute band keratopathy formation after penetrating keratoplasty: A case report. J Acute Dis. 2015 Oct;4(4):338-340.

4. Jhanji V, Rapuano CJ, Vajpayee RB. Corneal calcific band keratopathy. Curr Opin Ophthalmol. 2011 Jul;22(4):283-289.

5. Yanoff M, Duker JS. Ophthalmology. 3rd. ed. Mosby Elsevier inc.; 2009. 1528.

6. de Ortueta D, Schreyger F, Baatz H. Band keratopathy: a modified treatment. Eur J Ophthalmol. 2006 Jul-Aug;16(4):618-520.

7. Ali SF, Edmond JC, Suelflow JR, Coats DK, Yen KG. Band keratopathy in children previously treated with diode laser for type 1 retinopathy of prematurity. J AAPOS. 2019 Aug;23(4):232-234.

8. Nascimento H, Yasuta MK, Marquezan MC, et al. Uveitic band keratopathy: child and adult. J Ophthalmic Inflamm Infect. 2015 Dec;5(1):35.

9. Pavicić-Astalos J, Lacmanović-Loncar V, Petric-Vicković I, et al. Eye drops preservative as the cause of corneal band keratopathy in long-term pilocarpine hydrochloride treatment. Acta Clin Croat. 2012 Mar;51(1):107-111.

10. Elad Moisseiev, Assaf Gal, Lia Addadi, Dan Caspi, Gabi Shemesh, Adi Michaeli. Acute calcific band keratopathy: Case report and literature review. J Cataract Refract Surg. 2013;39(2):292-294.

11. Weng SF, Jan RL, Chang C, et al. Risk of Band Keratopathy in Patients with End-Stage Renal Disease. Sci Rep. 2016;6:28675.

12. Myška V, Havlůjová L. Primární zonulární keratopatie [Primary zonular keratopathy]. Cesk Oftalmol. 1966;22(5):386-391. Czech.

13. Al-Hity A, Ramaesh K, Lockington D. EDTA chelation for symptomatic band keratopathy: results and recurrence. Eye (Lond). 2018 Jan;32(1):26-31.

14. Bee CR, Koenig LR, Hwang ES, Koenig SB. Removal of calcific band keratopathy without ethylenediaminetetraacetic acid (EDTA) in eyes with limited visual potential. Clin Ophthalmol. 2018 Oct 1;12:1895-1899.

15. Mansour AM, Haddad R. Optical coherence tomography of band keratopathy. BMJ Case Rep. 2016 Dec 30;2016:bcr2016218216.

16. Autrata R, Rehůrek J, Holousová M. Přínos PTK v léčbĕ povrchových afekcí rohovky u dĕtí [Phototherapeutic keratectomy in the treatment of corneal surface disorders in children]. Cesk Slov Oftalmol. 2002;58(2):105-111. Czech.

17. Najjar DM, Cohen EJ, Rapuano CJ, Laibson PR. EDTA chelation for calcific band keratopathy: results and long-term follow-up. Am J Ophthalmol. 2004 Jun;137(6):1056-1064.

18. Nevyas AS, Raber IM, Eagle RC Jr, Wallace IB, Nevyas HJ. Acute band keratopathy following intracameral Viscoat. Arch Ophthalmol. 1987 Jul;105(7):958-964.

19. Yang YL, Jian Q, Liu B, et al. Fourier-domain optical coherence tomography-guided phototherapeutic keratectomy for the treatment of anterior corneal scarring. Int J Ophthalmol. 2020 Nov 18;13(11):1720-1726.

20. Im SK, Lee KH, Yoon KC. Combined ethylenediaminetetraacetic acid chelation, phototherapeutic keratectomy and amniotic membrane transplantation for treatment of band keratopathy. Korean J Ophthalmol. 2010 Apr;24(2):73-77.

21. Spadea L, Giannico MI, Iannaccone A, Pistella S. Excimer laser-assisted phototherapeutic keratectomies combined to EDTA chelation for the treatment of calcific band keratopathy. Eur J Ophthalmol. 2020 Nov 5:1120672120969033.